Attralus

Biotechnology Research • Naples, Florida, United States • 21-50 Employees

Company overview

Headquarters	Naples, Florida, United States
Website	attralus.com
NAICS	541714
Employees	21-50
Socials

Key Contacts at Attralus

Spencer Guthrie

Chief Executive Officer

Jennifer Simpson

Director Of Clinical Operations

Chris Vessell

Senior Director, Cmc Radiodiagnostics

Susan Gronwald

Sr. Director Cmc Project Management

Lesley Davis

Director Of Quality

Alex Sienkiewicz

Director Of Manufacturing And Process Development

Suganya Selvarajah

Director Of Biology, Research And Development, Cns Diseases

Scott Stephens

Senior Director

Attralus Email Formats

Attralus uses 3 email formats. The most common is {first initial}{last name} (e.g., jdoe@attralus.com), used 81% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@attralus.com	81%
{first initial}	j@attralus.com	9.5%
{last name}{last name}	doedoe@attralus.com	9.5%

About Attralus

Attralus is a clinical stage biopharmaceutical company focused on creating transformative medicines to improve the lives of patients with systemic amyloidosis. Our proprietary pan-amyloid removal (PAR) therapeutics are designed to directly bind to and remove toxic amyloid in organs and tissues. By targeting the universal disease-causing pathology in all systemic amyloidosis diseases, PAR therapeutics have the potential to treat and reverse disease in patients with all types and stages of systemic amyloidosis.

Attralus revenue & valuation

Annual revenue	$5,000,000
Revenue per employee	$173,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$16,000,000
Total funding	$172,000,000